Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Current Medical Research and Opinion

Topics

Medicine

Internal Medicine

Endocrinology

Endocrinology, Diabetes And Metabolism

Pediatrics, Perinatology And Child Health

Show all topics

DOI

10.1080/03007995.2024.2401096